Expert Opinion. Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians different from Caucasians?

by Tan DSY
Published 2020

Letter regarding Article, "Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention"

by Aw JWX, Tan DSY, Goh LL
Published 2020

Patients' and Caregivers' Attitudes Towards Deprescribing in Singapore

by Kua, C.H., E. Reeves, Tan DSY
Published 2020

Switching of P2Y12 Inhibitors in Acute Coronary Syndromes

by Leong WQ, Kim JH, Aw JWX, Tan DSY
Published 2020

Sex Differences in 1-Year Rehospitalisation for Heart Failure and Myocardial Infarction after Primary Percutaneous Coronary Intervention

by Zheng HL, Foo LL, Tan HC, Tan DSY
Published 2020

Association between total daily doses with duration of hospitalization among readmitted patients in a multi ethnic asian population

by Teo V, Toh MR, Kwan YH, Raaj S, Tan DSY, Tan JZY
Published 2020

Asian study of clopidogrel (ASCLOP) responsiveness: The contributions of genetic and non-genetic factors

by Tan, D.S.Y., Yeo, A.H.L., Ho, H.K., Wee, H.L., Ong, H.Y.
Published 2014